Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Thoracic and Cardiovascular Surgery|December 31, 1998
Results of reoperation on the upper esophageal sphincterG Rocco, C Deschamps, E Martel, et al.
Oncology Reports|February 22, 2013
Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancerG Pirozzi, V Tirino, R Camerlingo, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|January 8, 2019
Nurse Competence Scale: psychometric assessment in the Italian contextI Notarnicola, A Stievano, M R De Jesus Barbarosa, et al.
Current Medicinal Chemistry|January 5, 2012
Bevacizumab in non small cell lung cancer: development, current status and issuesC Sandomenico, R Costanzo, G Carillio, et al.
Cell Death & Disease|May 4, 2013
TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fractionV Tirino, R Camerlingo, K Bifulco, et al.
The Annals of Thoracic Surgery|January 5, 2000
Prognostic factors after surgical treatment of lung cancer invading the diaphragmG Rocco, E A Rendina, A Meroni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-upJ Vansteenkiste, L Crinò, C Dooms, et al.
Drugs of Today (Barcelona, Spain : 1998)|October 23, 2010
Vandetanib: An overview of its clinical development in NSCLC and other tumorsA Morabito, M C Piccirillo, R Costanzo, et al.
The European Respiratory Journal|July 2, 2009
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)A Brunelli, A Charloux, C T Bolliger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in ItalyF Perrone, C Jommi, M Di Maio, et al.
Pageof 7